The incidence, prognosis and survival of primary breast lymphoma: A SEER experience.

Authors:

Abstract
E19026 Background: Primary breast lymphoma (PBL) are rare neoplasms involving breasts and draining lymph nodes without evidence of disease elsewhere. By definition PBL are stage IE and IIE non-Hodgkin’s lymphoma (NHL). The staging of bilateral tumors is controversial. We evaluated the trends of incidence and prognosis in PBL. Methods: We analyzed all cases of PBL registered in the Surveillance, Epidemiology, and End Results (SEER) database from 1983 to 2012. Age-adjusted incidence and survival rates were calculated. K-M curves were plotted and log-rank statistics computed to detect differences between survival curves for sex, race, stage, radiation, age, and year of diagnosis. Results:: 1545 cases of PBL were identified. The cumulative age standardized incidence rate per 100, 000 was 0.147. The rate increased with advancing age from .032 per 100,000 (95% CI; .026-.038) in below 50 years old to .767 (95% CI; .66-.89) per 100,000 above 80 years. The incidence rate per 100,000 almost doubled from .094 (95% CI; .08-.11) during 1983-92 to.172 (95%CI; .16-.19) in 2003-12. (p = .02) The median overall survival (OS) (115 months; 95% CI 103-127) was better than all NHL (median OS 97 months; 95% CI 95.6-98.4) (p = .03). 30 patients had bilateral tumors staged as I and II NHL in the SEER database. The outcome in bilateral tumors (median OS 115 months: 95% CI 102.8 – 127.2) was similar to unilateral tumors. Stage I (HR .46-.67) and age below 50 years (HR .05 -.108) were the strongest predictors of favorable outcome on multivariate analysis. (P = 0.00) Histological type didn’t affect the prognosis in PBL unlike in NHL. (P = 0.15). Median OS increased from 51 months (95% CI; 55-95) during 1983-92 to 124 months (95% CI; 103-127) in 2003-12 (p = .03). No differences were seen in the distribution of stage or age at diagnosis among these time periods. Conclusions: The incidence of PBL is increasing in United States. The prognosis of bilateral tumors is similar to the stage I and II unilateral tumors and thus current view of staging bilateral tumors as stage IV may not be valid. The survival of PBL patients is better than NHL and continues to improve. Prognosis is not affected by histological type unlike in NHL. Age and stage are the strongest predictors of outcome in PBL.